Long-term outcomes of colectomy surgery among patients with ulcerative colitis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://link.springer.com/content/pdf/10.1186/s40064-015-1350-7.pdf
Reference45 articles.
1. Berndtsson I, Oresland T (2003) Quality of life before and after proctocolectomy and IPAA in patients with ulcerative proctocolitis—a prospective study. Colorectal Dis 5:173–179
2. Bewtra M, Kilambi V, Fairchild AO et al (2014) Patient preferences for surgical versus medical therapy for ulcerative colitis. Inflamm Bowel Dis 20(1):103–114
3. Bouguen G, Roblin X, Bourreille A et al (2010) Infliximab for refractory ulcerative proctitis. Aliment Pharmacol Ther 31:1178–1185
4. Byrne CM, Tan KK, Young JM et al (2014) Patient and clinician preferences for surgical and medical treatment options in ulcerative colitis. Colorectal Dis 16(4):285–292
5. Dayan B, Turner D (2012) Role of surgery in severe ulcerative colitis in the era of medical rescue therapy. World J Gastroenterol 18:3833–3838
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and Safety of Etrolizumab in the Treatment of Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;American Journal of Therapeutics;2024-09
2. Etrolizumab as an induction and maintenance therapy for ulcerative colitis: A systematic review and meta‐analysis of randomized controlled trials;JGH Open;2024-04
3. Etrolizumab as induction and maintenance therapy in patients with moderately to severely active ulcerative colitis: a protocol of systematic review and meta-analysis of placebo-controlled, randomised clinical trials;BMJ Open;2024-01
4. Comparative of the effectiveness and safety of biological agents, small molecule drugs, and microbiome therapies in ulcerative colitis: Systematic review and network meta-analysis;Medicine;2023-10-27
5. A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score;Clinical and Translational Science;2023-09-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3